• SENSEX 76,909.68
    -325.78 (--0.42%)
  • BANKNIFTY 57,262.40
    -235.40 (--0.41%)
  • Aster DM Quality
    766.10 519.80(%)
  • Dhoot Transmission
    1,436.85 1,306.25(%)
  • Oberoi Realty
    1,831.50 1,390.15(%)
  • Abbott India
    26,302.50 25,164.00(%)
  • Pfizer
    4,965.00 5,878.55(%)
  • Cupid
    291.00 298.95(%)
  • Cyient
    902.75 1,282.40(%)
  • HDFC Bank
    715.05 722.00(%)
  • Netweb Technol.
    5,024.00 2,037.65(%)
  • Himadri Special
    702.00 420.00(%)
  • SBI
    1,041.30 798.60(%)
  • Reliance Industries
    1,304.00 1,250.55(%)
  • Bharti Airtel
    1,921.35 1,745.00(%)
  • Kaynes Tech
    3,825.00 7,705.00(%)
  • Alkem Lab
    5,369.15 5,085.00(%)
  • Molbio Diagnosti
    1,013.65 925.80(%)
  • ICICI Bank
    1,391.10 1,187.55(%)
  • Vedant Fashions
    545.15 794.55(%)
  • Triveni Turbine
    561.35 428.50(%)
  • Power Fin.Corpn.
    376.50 486.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Acutaas Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 73056.0
  • ISIN : INE00FF01025
3,391.40 193 (6.04%)
  • As on 19 Aug 2026 (EOD)

  • Today’s Low

    3,189.90

  • Today’s High

    3,399.80

  • Open

    3,190.00

  • Perv Close

    3,198.20

  • 52W Low

    1,302.00

  • 52W High

    3,740.00

Key Indicators

  • P/E(TTM)

    69.83

  • Mar.Cap (₹Cr.)

    27,765.77

  • Div & Yield %

    0.07

  • Book Value(₹)

    203.78

  • Debt-Equity Ratio

    6.04

  • AGM Date

    18-Aug-2026

  • EPS

    48.54

  • P/E Ratio

    69.83

Financials Ratios

  • Debt-Equity Ratio

    0.17

  • Mar.Cap (₹Cr.)

    27,765.77

  • RONW (%)

    10.67

  • ROCE (%)

    16.07

Score Board

  • Equity (₹ in Cr.)

    40.94

  • BV (₹)

    203.80

  • Sales( ₹ in Cr.)

    1,323.79

  • NP (in Cr.)

    366.17

  • NP Var(%)

    132.0

  • Div%

    50.0

  • CPS (₹)

    48.80

  • EPS (₹)

    44.70

  • Traded Value (₹ in Lakhs)

    27,749.81

  • 52 Week High

    3,740.00

  • 52 Week Low

    1,302.00

  • Price BSE

    3389.0

  • Price NSE

    3,391.00

  • Market Capital( in Cr.)

    27,749.81

  • P/C Ratio

    69.50

  • P/E Ratio

    75.80

  • Price Vs.BV

    44.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 989.83 687.58 616.73 520.14 340.61 239.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 989.83 687.58 616.73 520.14 340.61 239.64
Other Income 18.34 13.79 4.32 2.76 1.33 2.77
Stock Adjustments 18.65 26.94 14.96 9.50 -4.81 8.99
Total Income 1,026.82 728.31 636.01 532.40 337.13 251.40
EXPENDITURE :            
Raw Materials 566.84 434.96 345.85 282.33 174.87 137.96
Power and Fuel Cost 29.99 25.69 22.28 21.40 5.26 4.53
Employee Cost 80.95 60.92 48.84 41.37 20.99 12.77
Other Manufacturing Expenses 51.23 47.46 46.71 49.53 40.65 34.54
Selling and Administration Expenses 45.84 32.33 36.56 27.22 11.47 15.37
Miscellaneous Expenses 8.49 37.26 8.78 2.61 2.35 2.36
Employee Benefit Expenses 80.95 60.92 48.84 41.37 20.99 12.77
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 783.34 638.61 509.03 424.45 255.59 207.54
Operating Profit 243.48 89.69 126.98 107.94 81.53 43.86
Interest 5.86 5.89 2.41 6.41 5.62 5.59
Gross Profit 237.62 83.80 124.57 101.53 75.91 38.27
Depreciation 24.05 14.69 12.34 10.08 4.19 3.52
Profit Before Tax 213.57 69.11 112.23 91.45 71.72 34.75
Current Tax 46.97 20.91 26.38 16.72 17.56 6.80
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 7.06 4.51 2.50 2.78 0.16 0.49
Reported Net Profit 159.55 43.68 83.34 71.95 54.00 27.47
Extraordinary Items 1.55 -15.35 -0.55 -0.10 -0.61 -0.69
Adjusted Net Profit 158.00 59.03 83.89 72.05 54.61 28.16
Adjustment below Net Profit -0.11 -0.09 0.17 0.00 -21.03 -0.63
P & L Balance brought forward 308.24 275.58 203.00 131.28 97.48 70.64
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.28 10.93 10.93 0.00 0.00 0.00
P & L Balance carried down 455.40 308.24 275.58 203.23 130.45 97.48
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 0.00 0.00
Dividend Per Share(Rs) 1.50 3.00 3.00 3.00 0.00 0.00
Earnings Per Share-Unit Curr 19.49 11.84 22.87 19.75 17.14 26.16
Earnings Per Share(Adj)-Unit Curr 9.75 5.92 11.44 9.88 - -
Book Value 160.21 183.05 161.04 142.16 52.05 102.84
Book Value(Adj)-Unit Curr 80.11 91.53 80.52 71.08 - -

Shareholding Pattern

  • Promoter Group

    32.66%

  • Public Share Holding

    67.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,741,416 32.66 26,741,416 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,741,416 32.66 26,741,416 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,473 0.01 8,473 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,570 0.00 1,570 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,690,137 21.61 17,690,137 244
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,957,611 3.61 2,957,611 14
Mutual Funds / UTI 11,598,952 14.17 11,598,952 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,453,086 1.77 1,453,086 39
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 33,709,829 41.17 33,709,829 331
2] Non Institution
Bodies Corporate 1,026,375 1.25 1,026,375 821
Clearing Members 163,989 0.20 163,989 29
Directors of their Relatives 623,200 0.76 623,200 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,071,708 1.31 1,071,708 4,079
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 481,820 0.59 481,820 2,522
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,777,426 8.28 6,777,426 19
Individuals holding nominal share capital up to Rs. 1 lakh 11,004,545 13.44 11,004,545 117,586
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 75,338 0.09 75,338 11
Others 2,500 0.00 2,500 2
Sub Total 21,419,877 26.16 21,419,877 125,235
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 81,871,122 100.00 81,871,122 125,569

Company Background

Acutaas Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Acutaas Chemicals Ltd
  • BSE Code : 73056.0
  • ISIN : INE00FF01025

  • Incorporation Year

    2007

  • Registered Office

    Plot No 440/4 5&6
    Road No 82/A GIDC Sachin, Surat,
    Gujarat-394230

  • Telephone

    91-261-2397193/91-7227977744

  • FAX

    91-261-2398436

  • Chairman

    Nareshbhai Ramjibhai Patel

  • Managing Director

  • Company Secretary

  • Auditor

    Maheshwari & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Acutaas Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Acutaas Chemical 3,389.45 1,008.17 989.83 69.83 19.91
Abbott India 26,587.05 7,217.19 6,929.05 34.99 43.78
Astrazeneca Phar 7,649.85 2,304.07 2,275.58 112.75 27.86
Glaxosmi. Pharma 2,883.20 3,932.76 3,790.20 46.06 58.17
Novartis India 1,594.05 398.23 356.27 40.25 16.64
Cipla 1,431.85 20,102.60 18,979.95 37.63 13.88
Bliss GVS Pharma 545.45 773.53 729.81 50.65 12.51
Amrutanjan Healt 488.65 469.50 451.82 26.17 21.89
Fermenta Biotec. 454.50 474.15 450.25 21.22 18.77
Guj. Themis Bio. 372.35 152.47 150.80 83.30 27.21
Ambalal Sarabhai 47.70 19.52 3.94 88.33 6.77